The Relationship of Fetuin-A with Coronary Calcification, Carotid Atherosclerosis, and Mortality Risk in Non-Dialysis Chronic Kidney Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective This study investigated the relationship of fetuin-A with coronary calcification, carotid atherosclerosis, and mortality risk in non-dialysis chronic kidney disease (CKD). Methods The study included 135 adult patients with CKD at stages 3–5, who were divided into coronary artery calcification (CAC) and non-CAC groups. We excluded current smokers and individuals with diabetes mellitus, inflammatory conditions, liver diseases, acute kidney failure, chronic hemodialysis, and cancer. We conducted kidney function tests, complete blood counts, and measured serum levels of fetuin-A, tumor necrosis factor-alpha (TNF-α), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), total cholesterol (TC), total triglycerides (TG), high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. Cardiac spiral computed tomography was used to calculate the CAC score, employing the Agatston method. Carotid ultrasonography was performed to assess carotid intima-media thickness (CIMT) and to detect the presence of plaques. Results CAC patients had considerably higher levels of TNF-α (p<0.001), IL-6 (p<0.001), hs-CRP (p=0.006), TC, TG, parathyroid hormone (PTH) (p<0.001) and phosphorus (p<0.001) than non-CAC patients. They also had significantly lower levels of fetuin-A (p<0.001). Fetuin-A was considerably lower in CKD subgroups as CKD progressed. Fetuin-A (p=0.046), age (p=0.009), TNF-α (p=0.027), IL-6 (p=0.005), TG (p=0.002), PTH (p=0.002), and phosphorus (p=0.004) were significant predictors of CAC. CAC and fetuin-A were strong predictors of all-cause mortality and cardiovascular (CV) mortality. Fetuin-A was a significant predictor of CIMT (p=0.045). Conclusion Fetuin-A reliably predicted CAC and CIMT. Fetuin-A and CAC emerged as significant risk factors for all-cause and CV mortality in non-dialysis CKD.
Abstract
Objective This study investigated the relationship of fetuin-A with coronary calcification, carotid atherosclerosis, and mortality risk in non-dialysis chronic kidney disease (CKD). Methods The study included 135 adult patients with CKD at stages 3–5, who were divided into coronary artery calcification (CAC) and non-CAC groups. We excluded current smokers and individuals with diabetes mellitus, inflammatory conditions, liver diseases, acute kidney failure, chronic hemodialysis, and cancer. We conducted kidney function tests, complete blood counts, and measured serum levels of fetuin-A, tumor necrosis factor-alpha (TNF-α), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), total cholesterol (TC), total triglycerides (TG), high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol. Cardiac spiral computed tomography was used to calculate the CAC score, employing the Agatston method. Carotid ultrasonography was performed to assess carotid intima-media thickness (CIMT) and to detect the presence of plaques. Results CAC patients had considerably higher levels of TNF-α (p<0.001), IL-6 (p<0.001), hs-CRP (p=0.006), TC, TG, parathyroid hormone (PTH) (p<0.001) and phosphorus (p<0.001) than non-CAC patients. They also had significantly lower levels of fetuin-A (p<0.001). Fetuin-A was considerably lower in CKD subgroups as CKD progressed. Fetuin-A (p=0.046), age (p=0.009), TNF-α (p=0.027), IL-6 (p=0.005), TG (p=0.002), PTH (p=0.002), and phosphorus (p=0.004) were significant predictors of CAC. CAC and fetuin-A were strong predictors of all-cause mortality and cardiovascular (CV) mortality. Fetuin-A was a significant predictor of CIMT (p=0.045). Conclusion Fetuin-A reliably predicted CAC and CIMT. Fetuin-A and CAC emerged as significant risk factors for all-cause and CV mortality in non-dialysis CKD.
참고문헌 (73)
- Perez-Gomez MV, "Clarifying the concept of chronic kidney disease for non-nephrologists", Clin Kidney J, 12, pp.258~261 (2019)
- Kazancioğlu R, "Risk factors for chronic kidney disease : an update", Kidney Int Suppl(2011), 3, pp.368~371 (2013)
- Mohamed ON, "The relationship between asymptomatic atherosclerosis and hepcidin-25 in chronic kidney disease patients", Ann Saudi Med, 43, pp.298~308 (2023)
- Valdivielso JM, "Atherosclerosis in chronic kidney disease : more, less, or just different?", Arterioscler Thromb Vasc Biol, 39, pp.1938~1966 (2019)
- Poznyak AV, "Atherosclerosis specific features in chronic kidney disease(CKD)", Biomedicines, 10, pp.2094~ (2022)
- Pateinakis P, "Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients", BMC Nephrol, 14, pp.122~ (2013)
- Birukov A, "Fetuin-A and risk of diabetes-related vascular complications : a prospective study", Cardiovasc Diabetol, 21, pp.6~ (2022)
- Ozkan A, "Determination of the relationship between healthy lifestyle behaviors, physical fitness, and risk factors of coronary heart diseases in university students", Educ Sci, 8, pp.51~ (2018)
- Zheng J, "The relationship between fetuin-A and coronary atherosclerotic heart disease(CHD)and CHD-related risk factors : a retrospective study", Medicine(Baltimore), 100, pp.e27481~ (2021)
- Lee CT, "Biomarkers associated with vascular and valvular calcification in chronic hemodialysis patients", Dis Markers, 34, pp.229~235 (2013)
- Osorio A, "Biochemical markers of vascular calcification in elderly hemodialysis patients", Mol Cell Biochem, 374, pp.21~27 (2013)
- Pencak P, "Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients", BMC Nephrol, 14, pp.10~ (2013)
- Kanbay M, "Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease", Clin J Am Soc Nephrol, 5, pp.1780~1786 (2010)
- Ix JH, "Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study", Nephrol Dial Transplant, 21, pp.2144~2151 (2006)
- Inker LA, "New creatinine-and cystatin C-based equations to estimate GFR without race", N Engl J Med, 385, pp.1737~1749 (2021)
- Wilkieson TJ, "Coronary artery calcification, cardiovascular events, and death : a prospective cohort study of incident patients on hemodialysis", Can J Kidney Health Dis, 2, pp.29~ (2015)
- Youssef G, "Coronary calcium : new insights, recent data, and clinical role", Curr Cardiol Rep, 15, pp.325~ (2013)
- Neves PO, "Coronary artery calcium score : current status", Radiol Bras, 50, pp.182~189 (2017)
- Hu H, "A cutoff point for arterial stiffness using the cardio-ankle vascular index based on carotid arteriosclerosis", Hypertens Res, 36, pp.334~341 (2013)
- Budoff MJ, "Progression of coronary artery calcium predicts all-cause mortality", JACC Cardiovasc Imaging, 3, pp.1229~1236 (2010)
- Wang MC, "Association between coronary artery calcium and all-cause mortality : a large single-center retrospective cohort study", PLoS One, 17, pp.e0276659~ (2022)
- Chen J, "Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease", JAMA Cardiol, 2, pp.635~643 (2017)
- Wang XR, "Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease", Ren Fail, 43, pp.1172~1179 (2021)
- Adeney KL, "Association of serum phosphate with vascular and valvular calcification in moderate CKD", J Am Soc Nephrol, 20, pp.381~387 (2009)
- Jean G, "Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients", Nephron Clin Pract, 120, pp.c132~ (2012)
- Bastard P, "Autoantibodies against type I IFNs in patients with life-threatening COVID-19", Science, 370, pp.eabd4585~ (2020)
- Fernández-Martín JL, "Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients : the COSMOS study", Nephrol Dial Transplant, 30, pp.1542~1551 (2015)
- Hiyamuta H, "Association of hyperphosphatemia with an increased risk of sudden death in patients on hemodialysis : ten-year outcomes of the Q-cohort study", Atherosclerosis, 316, pp.25~31 (2021)
- Naves-Díaz M, "Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES study", Nephrol Dial Transplant, 26, pp.1938~1947 (2011)
- Reiss AB, "CKD, arterial calcification, atherosclerosis and bone health : inter-relationships and controversies", Atherosclerosis, 278, pp.49~59 (2018)
- Lai J, "Research progress on the relationship between coronary artery calcification and chronic renal failure", Chin Med J(Engl), 131, pp.608~614 (2018)
- Amdur RL, "Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD : findings from the CRIC study", Am J Kidney Dis, 73, pp.344~353 (2019)
- Knight EL, "Kidney dysfunction, inflammation, and coronary events : a prospective study", J Am Soc Nephrol, 15, pp.1897~1903 (2004)
- Viegas C, "The interplay between mineral metabolism, vascular calcification and inflammation in chronic kidney disease(CKD) : challenging old concepts with new facts", Aging(Albany NY), 11, pp.4274~4299 (2019)
- Visconti L, "Lipid disorders in patients with renal failure : role in cardiovascular events and progression of chronic kidney disease", J Clin Transl Endocrinol, 6, pp.8~14 (2016)
- Sarwar N, "Triglycerides and the risk of coronary heart disease : 10, 158 incident cases among 262, 525 participants in 29 Western prospective studies", Circulation, 115, pp.450~458 (2007)
- Arntzenius AC, "Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial", N Engl J Med, 312, pp.805~811 (1985)
- Cano-Megías M, "Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease : a prospective long-term follow-up study", BMC Nephrol, 20, pp.188~ (2019)
- Ceja-Galicia ZA, "The development of dyslipidemia in chronic kidney disease and associated cardiovascular damage, and the protective effects of curcuminoids", Foods, 12, pp.921~ (2023)
- Cottone S, "Relationship of fetuin-A with glomerular filtration rate and endothelial dysfunction in moderate-severe chronic kidney disease", J Nephrol, 23, pp.62~69 (2010)
- Deepa P, "A study of serum fetuin-a level in patients with chronic kidney disease", master, pp.2013
- Alderson HV, "FGF-23 and osteoprotegerin but not fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3–5", Nephrology(Carlton), 21, pp.566~573 (2016)
- Li W, "A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation", PLoS One, 6, pp.e16945~ (2011)
- Turkmen K, "Fetuin-A, inflammation, and coronary artery calcification in hemodialysis patients", Indian J Nephrol, 21, pp.90~94 (2011)
- Kirkpantur A, "Association among serum fetuin-A level, coronary artery calcification, and bone mineral densitometry in maintenance hemodialysis patients", Artif Organs, 33, pp.844~854 (2009)
- Mutluay R, "Serum fetuin-A is associated with the components of MIAC(malnutrition, inflammation, atherosclerosis, calcification)syndrome in different stages of chronic kidney disease", Turk J Med Sci, 49, pp.327~335 (2019)
- Hermans MM, "Association of serum fetuin-A levels with mortality in dialysis patients", Kidney Int, 72, pp.202~207 (2007)
- Caglar K, "Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients", Clin J Am Soc Nephrol, 3, pp.61~68 (2008)
- Mehrotra R, "Serum fetuin-A in nondialyzed patients with diabetic nephropathy : relationship with coronary artery calcification", Kidney Int, 67, pp.1070~1077 (2005)
- Ossareh S, "Association of serum fetuin-a with vascular calcification in hemodialysis patients and its’ impact on 3-year mortality", Iran J Kidney Dis, 14, pp.500~509 (2020)
- Mikami S, "Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients", Hypertens Res, 31, pp.1163~1170 (2008)
- Ulutas O, "Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients", Int Urol Nephrol, 50, pp.137~142 (2018)
- Ix JH, "Fetuin-A is not associated with mortality in chronic kidney disease", Kidney Int, 72, pp.1394~1399 (2007)
- Heiss A, "Structural basis of calcification inhibition by α 2-HS glycoprotein", fetuin-A. Formation of colloidal calciprotein particles, 2003, pp.278, 13333~13341
- Scialla JJ, "Biomarkers of vascular calcification and mortality in patients with ESRD", Clin J Am Soc Nephrol, 9, pp.745~755 (2014)
- Ciaccio M, "Changes in serum fetuin-A and inflammatory markers levels in end-stage renal disease(ESRD) : effect of a single session haemodialysis", Clin Chem Lab Med, 46, pp.212~214 (2008)
- Weikert C, "Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke", Circulation, 118, pp.2555~2562 (2008)
- Chekol Abebe E, "The structure, biosynthesis, and biological roles of fetuin-A : a review", Front Cell Dev Biol, 10, pp.945287~ (2022)
- Sevinc C, "The relationship between calcification inhibitor levels in chronic kidney disease and the development of atherosclerosis", Ren Fail, 43, pp.1349~1358 (2021)
- Sommer P, "High baseline fetuin-A levels are associated with lower atherosclerotic plaque progression as measured by 3D ultrasound", Atheroscler Plus, 45, pp.10~17 (2021)
- Guarneri M, "Subclinical atherosclerosis and fetuin-A plasma levels in essential hypertensive patients", Hypertens Res, 36, pp.129~133 (2013)
- Mori K, "Association of serum fetuin-A with carotid arterial stiffness", Clin Endocrinol(Oxf), 66, pp.246~250 (2007)
- Bakan A, "Serum fetuin-A level is not correlated with subclinical atherosclerosis in patients with amyloid A amyloidosis", Med J Bakirköy, 15, pp.280~286 (2019)
- Ix JH, "The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons : the Rancho Bernardo Study", J Am Coll Cardiol, 58, pp.2372~2379 (2011)
- Costa AF, "Association of PTH and carotid thickness in patients with chronic kidney failure and secondary hyperparathyroidism", J Bras Nefrol, 36, pp.315~319 (2014)
- Abajo M, "Mineral metabolism factors predict accelerated progression of common carotid intima-media thickness in chronic kidney disease : the NEFRONA study", Nephrol Dial Transplant, 32, pp.1882~1891 (2017)
- Blondon M, "25-Hydroxyvitamin D and parathyroid hormone are not associated with carotid intima-media thickness or plaque in the multi-ethnic study of atherosclerosis", Arterioscler Thromb Vasc Biol, 33, pp.2639~2645 (2013)
- Reis JP, "Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis", Atherosclerosis, 207, pp.585~590 (2009)
- Arzpeyma SF, "Studying the relationship between the risk factors of cardiovascular diseases and carotid intima-media thickness(CIMT)in renal patients undergoing hemodialysis admitted to Razi Hospital and Caspian Dialysis Center in Rasht, 2017", Rev Latinoam Hipertens, 13, pp.251~ (2018)
- Watanabe R, "Impact of cardiovascular calcification in nondialyzed patients after 24 months of follow-up", Clin J Am Soc Nephrol, 5, pp.189~194 (2010)
- Xiang X, "Coronary artery calcification in patients with advanced chronic kidney disease", BMC Cardiovasc Disord, 22, pp.453~ (2022)
- Chae HB, "Age is the strongest effector for the relationship between estimated glomerular filtration rate and coronary artery calcification in apparently healthy Korean adults", Endocrinol Metab(Seoul), 29, pp.312~319 (2014)
- Dai Z, "Pathophysiology and clinical impacts of chronic kidney disease on coronary artery calcification", J Cardiovasc Dev Dis, 10, pp.207~ (2023)